adeno-associated viruses

MDA partnered with a French muscle disease association to host a symposium on advancing gene therapy for neuromuscular diseases

posted on May 23, 2013 - 5:00am
Planning for the next generation of gene and stem cell therapies for muscular dystrophies — even as the first generation is still under development — was the theme of a joint symposium sponsored by MDA and the Association Française Contre les Myopathies (French Association Against Myopathies, or AFM) at the 16th annual meeting of the American Society of Gene & Cell Therapy (ASGCT).

New content is being added every day. Please check back again.